IPO Premiums
IPO calendar
EPListed

Earum Pharmaceuticals Limited

Fixed Price IPO · BSE

Price band
₹36 - ₹36
Lot size
3,000 shares
Issue amount
₹7 cr
Total subscription
0×
Current priceUnavailable
Listing price ₹36
Watch live price ↗
Opens
21 Jun 2019
Closes
26 Jun 2019
Allotment
1 Jul 2019
Listing
4 Jul 2019

Offer at a glance

Issue overview

Issue size
18,48,000 shares
Face value
₹10 per share
Minimum investment
₹1,08,000
Fresh issue
₹0 cr
Offer for sale
₹0 cr
Registrar
Bigshare Services Private Limited
Listing exchange
BSE
Maximum investment
₹1,08,000
Issue type
Fixed Price IPO
Shares before issue
43,19,910
Shares after issue
61,67,910

Lot sizes

CategoryLotsSharesAmount
RETAIL13,000₹1,08,000
HNI26,000₹2,16,000

Share reservation

Market Maker5.19%
HNI47.4%
RETAIL47.4%

Subscription & GMP

Subscription by category

Total subscribed0×

Subscription figures are awaiting publication.

GMP history

00.5126 Dec: ₹0
26 Dec₹026 Dec

Financial performance

Company financials

in Lakhs · Reported periods may include interim results.

Revenue & profitin Lakhs
01,0002,0003,0004,000Mar-16 · Revenue: 1,856.66Mar-16 · Profit after tax: 9.76Mar-16Dec-17 · Revenue: 2,333.95Dec-17 · Profit after tax: 15.98Dec-17Mar-18 · Revenue: 3,543.67Mar-18 · Profit after tax: 85.65Mar-18Dec-18 · Revenue: 3,449.85Dec-18 · Profit after tax: 86.51Dec-18
RevenueProfit after tax

Company information

Company profile

Incorporated in 2012, Ahmedabad-based Earum Pharmaceuticals Limited is engaged in the trading, marketing, and distribution of pharmaceutical formulation products, with a portfolio of around 125 formulations including multivitamins, gynaecology drugs, steroids, antibiotics, cerebral activators, and gastrointestinal medicines. The company is also involved in trading active pharmaceutical ingredients such as Amoxicillin Trihydrate IP, Levofloxacin Hemihydrate IP, and Albendazole IP, and operates through two main business models—marketing its own branded formulations and trading generic formulations of other brands, with about 24 products manufactured by third parties and sold under its own brand. Earum Pharmaceuticals operates a well-equipped warehouse in Ahmedabad, Gujarat, and has a presence in both domestic and international markets including South East Asia, Latin America, and Africa, while focusing on expanding its global footprint, improving market capabilities, and maintaining high-quality product standards.

Strengths

  • Wide Product Range: Offers a broad selection of products.
  • Experienced Promoter: Backed by 11+ years of industry experience.
  • Quality Assurance: Maintains high quality standards.

Promoters

Mr. Bhumishth Narendrabhai Patel

Mrs. Payal Bhumishth Patel

Registrar & documents

Lead manager

Hem Securities Limited

Registered office

G1, Ground Floor, V R Complex, Near Sanathal Cross Road, SP Ring Road, Sanathal, Ahmedabad, Gujarat-382210,

+91-79-48402525

[email protected]Company website ↗

Frequently Asked Questions

What is Earum Pharmaceuticals IPO GMP today?

Currently, Earum Pharmaceuticals IPO Grey Market Premium (GMP) is trading around ₹0 or awaiting active buyer-seller quotes in the grey market. The issue price is set at ₹36. Track daily updates on IPO Premiums as bidding numbers unfold.

What is the lot size and minimum investment for Earum Pharmaceuticals IPO?

The minimum bid lot size for Earum Pharmaceuticals IPO is 3,000 shares. At the cut-off price of ₹36 per share, retail investors need a minimum application amount of ₹1,08,000 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).

When will Earum Pharmaceuticals IPO allotment status be announced?

The allotment status for Earum Pharmaceuticals IPO is scheduled to be finalized on 1 Jul 2019. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Bigshare Services Private Limited's official portal or via BSE/NSE allotment portals.

How can I check Earum Pharmaceuticals IPO allotment status online by PAN?

To check Earum Pharmaceuticals IPO allotment status: 1) Visit the registrar portal (Bigshare Services Private Limited) or the BSE IPO allotment page. 2) Select 'Earum Pharmaceuticals Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.
Earum Pharmaceuticals IPO GMP Today, Subscription Status & Allotment Date | IPO Premiums